Friday, March 31, 2023 5:43:54 PM
https://www.google.com/search?client=firefox-b-1-d&q=google+scholar+brilacidin
If you want to attack a small biotech company like Ipix you must start with one question. Is the company science good or not good?
If the science is not good the job is easy. Learn everything possible and demonstrate the science is not good. Tell everyone the bad evidence. It should be finished quickly if the science is not good.
If the science is good it is more work. Creativity is maybe necessary in the attack. Here are some options. Bonne chance.
> The science is maybe not safe. This can be effective if the drug has not advance more than a Phase 2.clinical test.
> The company management is stupid or criminal or both. All small companies make mistakes. Find the mistakes and build a story in corruption and foolishness.
> The company will run out of money and fail. Every small biotech like Ipix needs a partner to go forward. If there is no partner and little money it is possible to build disappointment and despair for a good story.
> The market for the science is too small. Not enough people need the drug and no one will make any money. This one will not work well for Ipix and Brilacidin. But it is worth to try.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM